Proteinuria in pre-eclampsia.

PubWeight™: 0.84‹?›

🔗 View Article (PMID 4634090)

Published in J Obstet Gynaecol Br Commonw on February 01, 1973

Authors

M D Simanowitz, W G MacGregor, J R Hobbs

Articles by these authors

(truncated to the top 100)

Serum gamma-G-globulin levels and gestational age in premature babies. Lancet (1967) 3.37

Immune abnormalities associated with chronic mucocutaneous candidiasis. Cell Immunol (1973) 2.81

Paraproteins, benign or malignant? Br Med J (1967) 2.80

Immune imbalance in dysgammaglobulinaemia type IV. Lancet (1968) 2.74

Immunochemical studies on the serum, intestinal secretions and intestinal mucosa in patients with adult celiac disease and other forms of the celiac syndrome. Gastroenterology (1970) 2.66

Lymphocyte abnormality in chronic mucocutaneous candidiasis. Lancet (1970) 2.38

Reversal of clinical features of Hurler's disease and biochemical improvement after treatment by bone-marrow transplantation. Lancet (1981) 2.22

Monitoring of veno-occlusive disease after bone marrow transplantation by serum aminopropeptide of type III procollagen. Lancet (1993) 2.09

Complement metabolism in rheumatoid arthritis. I. Longitudinal studies. Ann Rheum Dis (1973) 2.04

Immunoglobulins in clinical chemistry. Adv Clin Chem (1971) 2.03

Six cases of gamma-D myelomatosis. Lancet (1966) 1.92

Gamma-M deficiency predisposing to meningococcal septicaemia. Br Med J (1967) 1.88

Serum-gamma-G-globulin levels in normal premature, post-mature, and "small-for-dates" newborn babies. Lancet (1968) 1.85

Secondary antibody deficiency. Proc R Soc Med (1968) 1.84

Immunochemical classes of myelomatosis. Including data from a therapeutic trial conducted by a Medical Research Council working party. Br J Haematol (1969) 1.83

Prolactin dependence in human breast cancers. Lancet (1972) 1.82

Standardisation of the mixed lymphocyte reaction. J Immunol Methods (1976) 1.77

Five cases of alpha chain disease. Gut (1972) 1.75

Immunocytoma o' mice an' men. Br Med J (1971) 1.74

Immunoglobulin deficiencies in an atopic population. Lancet (1970) 1.69

In-vitro oestrogen sensitivity of breast-cancer tissue as a possible screening method for hormonal treatment. Lancet (1972) 1.69

New oncofetal antigen for human pancreas. Lancet (1974) 1.66

Growth rates and responses to treatment in human myelomatosis. Br J Haematol (1969) 1.57

Immunological mystery of coeliac disease. Lancet (1969) 1.56

Detection of antibodies which can cooperate with lymphocytes. Lancet (1972) 1.51

Treatment of "primary" renal amyloidosis with melphalan. Lancet (1972) 1.51

Immunological studies on the mechanism of gold hypersensitivity reactions. Br Med J (1973) 1.50

Laboratory investigation of paraproteinaemia. J Clin Pathol (1988) 1.50

Uncomplicated HL-A matched sibling bone marrow graft for combined immune deficiency. Br Med J (1972) 1.49

Doubts using family history, age, alpha-fetoprotein and total human chorionic gonadotrophin in screening for Down's syndrome. Br J Obstet Gynaecol (1994) 1.43

Disturbances of the immunoglobulins. Sci Basis Med Annu Rev (1966) 1.43

Selection of hormone-dependent breast cancers. Br J Surg (1974) 1.42

A staining method for proteins and dextrans on cellulose acetate. Nature (1965) 1.40

Immunological features in a case of chronic granulomatous candidiasis and its treatment with transfer factor. Clin Exp Immunol (1972) 1.31

Coeliac disease, vasculitis, and cryoglobulinaemia. Gut (1972) 1.31

Paraproteins. Proc R Soc Med (1969) 1.31

The immunoglobulins in Hodgkin's disease. Immunology (1967) 1.28

An evaluation of the Hyland laser nephelometer PDQ system for the measurement of immunoglobulins. Ann Clin Biochem (1978) 1.28

Standardization of lymphocyte transformation to Candida immunogen. Clin Exp Immunol (1974) 1.25

Are some women's breast cancers androgen dependent? Lancet (1973) 1.21

Urinary isoamylases in the diagnosis of chronic pancreatitis. Gut (1967) 1.18

Serum proteins in liver disease. Proc R Soc Med (1967) 1.15

Dysgammaglobulinaemia type IV C. Clin Exp Immunol (1967) 1.14

Bone marrow suppression by antilymphocytic globulin. Br Med J (1975) 1.14

Assay of circulating immunoglobulins in patients with fibrosing alveolitis. Clin Exp Immunol (1967) 1.14

Bone marrow transplantation for severe aplastic anaemia. A review of the Westminster experience of 24 cases. Clin Lab Haematol (1983) 1.14

Rocket immunoselection for detection of heavy-chain diseases. Clin Chem (1974) 1.13

IgM paraproteins. J Clin Pathol Suppl (Assoc Clin Pathol) (1975) 1.11

Immmunosuppressive drugs in the treatment of autoimmune haemolytic anaemia. Proc R Soc Med (1968) 1.11

Value of serum C-reactive protein measurement in the management of bone marrow transplant recipients. Part I: Early transplant period. J Clin Pathol (1984) 1.10

Clinical significance of 7s IgM in monoclonal IgM diseases. Br Med J (1971) 1.09

Impaired IgA responses in coeliac disease. Lancet (1971) 1.09

Immunoglobulins in chronic cold haemagglutinin disease. Br J Haematol (1970) 1.08

Preparation of a calibration material for specific protein assay (SPS-01). Ann Clin Biochem (1984) 1.08

The serum paraprotein level related to the number of plasmacytoma-5536 cells in C3H mice. Br J Cancer (1970) 1.07

Timing of cyclosporin-A therapy for abrogation of HVG and GVH responses in rats. Lancet (1979) 1.07

Diminished mixed lymphocyte reaction in ankylosing spondylitis, relatives, and normal individuals all with HL-A 27. Ann Rheum Dis (1976) 1.07

The urinary excretion of human chorionic gonadotrophin in normal and abnormal pregnancy. J Obstet Gynaecol Br Commonw (1966) 1.07

Cardiac output at rest during pregnancy and the puerperium. Clin Sci (1966) 1.06

Non-immunoglobulin-bearing 'B' lymphocytes in chronic lymphatic leukaemia? Br J Haematol (1973) 1.06

A half-molecule GK plasmacytoma. Clin Exp Immunol (1969) 1.06

Heavy chain typing in IgG monoclonal gammopathies with special reference to cases of serum hyperviscosity and cryoglobulinaemia. Clin Exp Immunol (1971) 1.05

Immunoglobulins in warm-type autoimmune haemolytic anaemia. Lancet (1969) 1.04

7S anti-tumour antibodies and activated Fc in macrophage tumour cell interaction. Eur J Cancer (1973) 1.03

Value of serum C-reactive protein measurement in the management of bone marrow transplant recipients. Part II: Late post-transplant period. J Clin Pathol (1984) 1.00

An ABC of amyloid. Proc R Soc Med (1973) 0.99

Target cell death without added complement after cooperation of 7S antibodies with non-immune lymphocytes. Nat New Biol (1972) 0.99

Bone marrow transplantation for inborn errors. Lancet (1981) 0.98

Dermatological aspects of the use of Cyclosporin A for prophylaxis of graft-versus-host disease. Br J Dermatol (1984) 0.98

T-cell depletion and in vitro thymosin inducibility in asthmatic children. Clin Exp Immunol (1978) 0.98

Response of graft versus host disease to high doses of methyl prednisolone. Clin Lab Haematol (1981) 0.97

Monoclonal immunoglobulins from random mutations. Br J Cancer (1968) 0.96

Thymosin-inducible 'null' cells in atopic eczema. Br J Dermatol (1979) 0.96

Lymphocyte transformation to bacterial antigens in ankylosing spondylitis. Ann Rheum Dis (1979) 0.94

Technical Bulletin No. 34. Measurement of albumin in the sera of patients. Ann Clin Biochem (1975) 0.94

An immunochemical study of plasma cells in the intestinal mucosa in adult coeliac disease. Gut (1969) 0.93

Listeriosis in mother and fetus during the first trimester of pregnancy. Case report. Br J Obstet Gynaecol (1984) 0.93

Serum IgE elevation with tropical eosinophilia. Clin Allergy (1973) 0.92

Monitoring myelomatosis. Arch Intern Med (1975) 0.92

Successful thymus graft for T-cell deficiency in a 6-year-old boy. Br Med J (1975) 0.91

Further aspects of human immunoglobulin A deficiency. Ann Clin Biochem (2007) 0.91

Dysgammaglobulinaemia complicated by disseminated measles. Br Med J (1971) 0.91

Stress, cortisol, and lymphocyte subpopulations. Lancet (1984) 0.91

An analysis of the normal ranges of lymphocyte subpopulations in children aged 5-13 years. Eur J Pediatr (1996) 0.91

Modes of escape from therapeutic control in myelomatosis. Br Med J (1971) 0.90

Cytokine induction of neopterin production. Clin Exp Immunol (1991) 0.90

Younger age of presentation and extraosseous tumour in IgD myelomatosis. Br Med J (1969) 0.89

Monitoring immunocytoma. Minerva Med (1978) 0.89

Clinical applications of the continuous flow blood separator machine. Clin Exp Immunol (1975) 0.89

Beneficial effect of pre-transplant splenectomy on displacement bone marrow transplantation for Gaucher's syndrome. Lancet (1987) 0.87

Stress, cortisol concentrations, and lymphocyte subpopulations. Br Med J (Clin Res Ed) (1985) 0.87

Immunolgobulins and alimentary disease. Lancet (1968) 0.87

Immunoflobulins and malabsorption. Proc R Soc Med (1969) 0.87

Studies of the rat immune response to plasmacytoma 5563 in C3H mice. Br J Cancer (1970) 0.87

Standardisation in relation to human immunoglobulins. Ric Clin Lab (1981) 0.87

Transmission of toxoplasmosis by bone marrow transplant associated with Campath-1G. Bone Marrow Transplant (1992) 0.86

Standardisation in relation to human albumin. Ric Clin Lab (1981) 0.86

Total and allergen-specific IgE in relation to allergic response pattern following bone marrow transplantation. Clin Exp Immunol (1986) 0.86

Immunoglobulin levels in the Kaiapit and Upper Watut areas of New Guinea with special reference to the tropical splenomegaly syndrome. Trans R Soc Trop Med Hyg (1971) 0.86

Serum and urine proteins in pyelonephritis. Proc R Soc Med (1968) 0.86